Thomas Helleday#
| Membership Number: | 5566 |
| Membership type: | ORDINARY |
| Section: | CELL & DEVELOPMENTAL BIOLOGY |
| Elected: | 2021 |
| Main Country of Residence: | SWEDEN |
| Homepage(s): | https://helleday.org/ |
| ORCID: | 0000-0002-7384-092X |
Present and Previous Positions
- 2012 Torsten and Ragnar Söderberg Prof. in Translational Medicine, Strategic Prof. in Chemical Biology, Karolinska Inst, Stockholm
- 2018 - 2020 Professor of Translational Oncology, Director of Weston Park Cancer Center, University of Sheffield
- 2007 - 2011 Professor of Cancer Therapeutics, Univeristy of Oxford
- 2006 - 2011 Professor of Molecular genetics, Stockholm University
- 2006 - 2007 Professor of Cancer Genetics, University of Sheffield
- 2004 - 2006 Senior Lecturer, University of Sheffield
- 2004 - 2006 Research Fellow, Stockholm University
- 2000 - 2004 Lecturer, University of Sheffield
- 1999 - 2000 Postdiotoral Fellow, University of Sheffield
- 1999 Research associate, University of Stockholm
Fields of Scholarship
- Homologous recombination
- Synthetic lethality
- Targeted anti-cancer treatments
- DNA repair
- Translational medicine
- Small molecule inhibitors
- Stalled replication forks
Honours and Awards
- 2019 MADEatUNI, UK Universities
- 2016 Cancer Researcher of the Year, Swedish Cancer Society
- 2016 ERC Advanced Grant
- 2014 Erik K Fernström Prize in Medicine
- 2013 Göran Gustavsson Prize in Medicine
- 2012 Skandia´s Lennart Levi Prize
- 2010 ERC Advanced Grant
- 2010 Carcinogenesis Young Investigator Award
- 2008 Swiss Bridge Award, Swiss Cancer League and the International Union against Cancer
- 2008 The Svedberg Award, Swedish Association for Biochemistry and Molecular Biology
- 2007 European Association for Cancer research Young Cancer Researcher Award
- 2007 Hilda and Alfred Eriksson´s Prize
- 2006 British Association of Cancer Research-AstraZeneca Young Scientist Frank Rose Award
- 2005 The Eppendorf-Nature Young European Investigator Award
